Literature DB >> 11983286

Huperzine A, a nootropic agent, inhibits fast transient potassium current in rat dissociated hippocampal neurons.

Yang Li1, Guo-Yuan Hu.   

Abstract

The actions of huperzine A (HupA), a novel cholinesterase inhibitor, on the fast transient potassium current (IA) were investigated in CA1 pyramidal neurons acutely dissociated from rat hippocampus. HupA reversibly inhibited IA (IC(50) = 914 +/- 1 microM). The effect was voltage-independent and insensitive to atropine. Tacrine was eight times more potent than HupA (IC(50) = 115 +/- 2 M), whereas huperzine B had little effect. HupA slowed down the decay of IA and its recovery from inactivation. HupA had no effect on the steady-state inactivation, but hyperpolarized the activation curve of IA by 6 mV. The results suggest that HupA may act as a blocker at the external mouth of the A channel. The potential relevance of the inhibitory effect of HupA on IA to the treatment of Alzheimer's disease has been discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983286     DOI: 10.1016/s0304-3940(02)00167-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease.

Authors:  Jing-ying Jia; Qian-hua Zhao; Yun Liu; Yu-zhou Gui; Gang-yi Liu; Da-yuan Zhu; Chen Yu; Zhen Hong
Journal:  Acta Pharmacol Sin       Date:  2013-04-29       Impact factor: 6.150

Review 2.  Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels.

Authors:  Xian-Tao Li
Journal:  Metab Brain Dis       Date:  2022-01-31       Impact factor: 3.584

3.  Rivastigmine blocks voltage-activated K+ currents in dissociated rat hippocampal neurons.

Authors:  Yaping Pan; Xianghua Xu; Xiaoliang Wang
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

Review 4.  Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.

Authors:  Hai Yan Zhang; Han Yan; Xi Can Tang
Journal:  Cell Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.046

5.  SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.

Authors:  T T Zhou; L L Quan; L P Chen; T Du; K X Sun; J C Zhang; L Yu; Y Li; P Wan; L L Chen; B H Jiang; L H Hu; J Chen; X Shen
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.